Lin SW - Search Results

1

Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?

Chang SY, Lin SW, Hung CC. Chang SY, et al. Among authors: lin sw. Clin Infect Dis. 2009 Nov 1;49(9):1452-3; author reply 1453-4. doi: 10.1086/644494. Clin Infect Dis. 2009. PMID: 19824849 No abstract available.

2

Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan.

Tseng YT, Yang CJ, Chang SY, Lin SW, Tsai MS, Liu WC, Wu PY, Su YC, Luo YZ, Yang SP, Hung CC, Chang SC. Tseng YT, et al. Among authors: lin sw. Int J Infect Dis. 2014 Dec;29:12-7. doi: 10.1016/j.ijid.2014.08.012. Epub 2014 Oct 12. Int J Infect Dis. 2014. PMID: 25312984 Free article.

3

Therapeutic drug monitoring and pharmacogenetic study of HIV-infected ethnic Chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy.

Lee KY, Lin SW, Sun HY, Kuo CH, Tsai MS, Wu BR, Tang SY, Liu WC, Chang SY, Hung CC. Lee KY, et al. Among authors: lin sw. PLoS One. 2014 Feb 14;9(2):e88497. doi: 10.1371/journal.pone.0088497. eCollection 2014. PLoS One. 2014. PMID: 24551111 Free PMC article.

4

Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study.

Lee YC, Lin SW, Chen MY, Chang SY, Kuo CH, Sheng WH, Hsieh SM, Sun HY, Chang HY, Wu MR, Liu WC, Wu PY, Yang SP, Zhang JY, Su YC, Luo YZ, Hung CC, Chang SC. Lee YC, et al. Among authors: lin sw. PLoS One. 2015 Oct 14;10(10):e0140574. doi: 10.1371/journal.pone.0140574. eCollection 2015. PLoS One. 2015. PMID: 26465325 Free PMC article.

5

Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy.

Lin KY, Liao SH, Liu WC, Cheng A, Lin SW, Chang SY, Tsai MS, Kuo CH, Wu MR, Wang HP, Hung CC, Chang SC. Lin KY, et al. Among authors: lin sw. PLoS One. 2015 Sep 11;10(9):e0137660. doi: 10.1371/journal.pone.0137660. eCollection 2015. PLoS One. 2015. PMID: 26360703 Free PMC article.

6

Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy.

Huang SH, Lin SW, Chang SY, Lin YT, Chiang C, Hsiao CF, Sun HY, Liu WC, Su YC, Hung CC, Chang SC. Huang SH, et al. Among authors: lin sw, lin yt. Sci Rep. 2017 Nov 23;7(1):16187. doi: 10.1038/s41598-017-16483-2. Sci Rep. 2017. PMID: 29170492 Free PMC article.

7

Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study.

Huang SH, Lin SW, Chang SY, Lin YT, Sun HY, Liu WC, Su YC, Hung CC, Chang SC. Huang SH, et al. Among authors: lin sw, lin yt. J Microbiol Immunol Infect. 2020 Feb;53(1):60-68. doi: 10.1016/j.jmii.2018.05.001. Epub 2018 May 29. J Microbiol Immunol Infect. 2020. PMID: 29884449 Free article.

8

Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.

Huang YS, Chan CK, Tsai MS, Lee KY, Lin SW, Chang SY, Hung CC, Chang SC. Huang YS, et al. Among authors: lin sw. J Microbiol Immunol Infect. 2017 Oct;50(5):595-603. doi: 10.1016/j.jmii.2015.08.019. Epub 2015 Sep 9. J Microbiol Immunol Infect. 2017. PMID: 26514942 Free article.

9

Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.

Yang JJ, Huang CH, Liu CE, Tang HJ, Yang CJ, Lee YC, Lee KY, Tsai MS, Lin SW, Chen YH, Lu PL, Hung CC. Yang JJ, et al. Among authors: lin sw. PLoS One. 2014 Sep 3;9(9):e106141. doi: 10.1371/journal.pone.0106141. eCollection 2014. PLoS One. 2014. PMID: 25184238 Free PMC article.

10

Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study.

Tsai MS, Chang SY, Lin SW, Kuo CH, Sun HY, Wu BR, Tang SY, Liu WC, Su YC, Hung CC, Chang SC. Tsai MS, et al. Among authors: lin sw. J Microbiol Immunol Infect. 2017 Dec;50(6):789-797. doi: 10.1016/j.jmii.2015.12.012. Epub 2016 Jan 11. J Microbiol Immunol Infect. 2017. PMID: 26857335 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

774 results

Search Page

Filters